Yahoo! Finance: Top Stories

Liver Drug Stock Rockets 236% Amid FDA Approval As Sales Accelerate; Funds Load Up

Jun 17, 2025 - 18:02
 0
Liver Drug Stock Rockets 236% Amid FDA Approval As Sales Accelerate; Funds Load Up
Read More

Tags:

Previous Article

Conagra Brands, Inc. (CAG) Launches 50 New Frozen Items, Collaborates with Celeb...

Next Article

The Stock Is Up Almost 56,000% and Is Still a Buy

Related Posts

Salesforce Shows M&A Is Coming Back. What It Means for Investors.

Salesforce Shows M&A Is Coming Back. What It Means for ...

May 30, 2025  0

Amgen Announces Significant Survival Benefit for Lung Cancer Drug IMDELLTRA in Phase 3 Trial

Amgen Announces Significant Survival Benefit for Lung C...

Jun 16, 2025  0

Lululemon stock plunges as company's profit outlook misses forecasts on tariff, consumer worries

Lululemon stock plunges as company's profit outlook mis...

Jun 6, 2025  0